Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Adult (1)
- Anencephaly (1)
- Atelencephaly (1)
- Autosomal recessive (1)
- Brain (1)
-
- Efficacy (1)
- Face (1)
- Female (1)
- Guideline Adherence (1)
- HPV (1)
- Health Care Access (1)
- Health Care Cost (1)
- Health Care Evaluation (1)
- Holoprosencephaly (1)
- Human Papilloma Virus (1)
- Humans (1)
- Infant, Newborn (1)
- Medication Adherence (1)
- Missed Opportunities (1)
- Pregnancy (1)
- Prenatal Diagnosis (1)
- Quality of Care (1)
- Radial aplasia (1)
- Skull (1)
- Syndrome (1)
- Ultrasonography (1)
- Vaccine (1)
- File Type
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Xk Aprosencephaly And Anencephaly In Sibs, Phillip Townes, Karen Reuter, E. Rosquete, B. Magee
Xk Aprosencephaly And Anencephaly In Sibs, Phillip Townes, Karen Reuter, E. Rosquete, B. Magee
B. Dale Magee
Recent studies have suggested a causal and pathogenetic relationship between holoprosencephaly and anencephaly. In support of the proposed relationship we report a sibship that includes anencephalic male twins and a female infant with a severe form of alobar holoprosencephaly, radial aplasia, and oligodactyly. The upper limb and brain malformations are considered to represent aprosencephaly syndrome. The coexistence of anencephaly and aprosencephaly within a sibship suggests that XK aprosencephaly syndrome may be an autosomal recessive disorder.
Missed Opportunities In Hpv Vaccination, B. Dale Magee, Autumn S. Davidson, Leslie Regh
Missed Opportunities In Hpv Vaccination, B. Dale Magee, Autumn S. Davidson, Leslie Regh
B. Dale Magee
Objective: To use the 3 dose Human Papillomavirus (HPV) vaccine administration (given at 0, 1-2 and 6 months) to quantify opportunities to improve efficacy in the delivery of preventive health services. Methods: This was a retrospective, claims-based analysis using data provided by a single managed care plan. Female patients aged 9-26 who were continuously enrolled between 2009 through 2011 and received ≥ dose of the HPV vaccine during 2010 were analyzed. The proportion of initiators who did and did not completed the vaccine series, the timing and location of doses, and the number of outpatient visits during which the vaccine …